205
Participants
Start Date
March 5, 2018
Primary Completion Date
November 26, 2018
Study Completion Date
January 23, 2019
BP101
Investigational product BP101, nasal spray
Placebo
Placebo to Investigational product BP101, nasal spray
Алтайский государственный медицинский университет, Barnaul
Kazan State Medical University, Kazan'
Kuban State Medical University, Krasnodar
Central Clinical Hospital of the Russian Academy of Sciences, Moscow
N.A. Alexeev Moscow Psychiatric Clinical Hospital #1, Moscow
National Medical Research Center of Obstetrics, Gynecology and Perinatology, Moscow
National Medical Research Center of Psychiatry and Addiction named after V.P. Serbsky, Moscow
Clinical Psychiatry Hospital №1, Nizhny Novgorod
Orenburg Regional Clinical Psychiatric Hospital No. 2, Orenburg
City psychiatric hospital №7 named after academician I.P. Pavlov, Saint Petersburg
Doctor SAN Ltd., Saint Petersburg
Leningrad Regional Narcological Dispensary, Saint Petersburg
OrKli Hospital LLC, Saint Petersburg
Research center Eco-Safety LLC, Saint Petersburg
Samara Psychiatric Hospital, Samara
Regional Clinical Psychiatric Hospital of St. Sofia, Saratov
Engels Psycyatric hospital, Saratovskaya
"Clinic Hundred Years", Tomsk
Bashkir State Medical University, Ufa
Yaroslavl Regional Clinical Psychiatric Hospital, Yaroslavl
Ivix LLX
INDUSTRY